Zydus Wellness Shares Soar 10% on Motilal Oswal's 'Buy' Rating, Targets 35% Upside

• Zydus Wellness shares surged 10% in two days after Motilal Oswal initiated coverage with a 'Buy' rating.
• Motilal Oswal set a target price of Rs 575, projecting a 35% upside from the December 30 closing price.
• The brokerage highlights Zydus's diversified portfolio, leadership in wellness categories, and alignment with global consumption megatrends.
• Recent acquisitions like Naturell and Comfort Click have expanded Zydus's presence in high-protein snacks and preventive health.
• Motilal Oswal expects 14% organic EBITDA CAGR and 36% consolidated EBITDA CAGR for FY25-28, seeing a strong risk-reward profile.

Why It Matters: Motilal Oswal's 'Buy' rating and 35% upside target fueled a 10% surge in Zydus Wellness shares.